Vycor Medical (VYCO) Research & Development (2023)
Vycor Medical (VYCO) has disclosed Research & Development for 5 consecutive years, with $7250.0 as the latest value for Q3 2023.
- Quarterly Research & Development changed N/A to $7250.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $20308.0 through Sep 2023, changed N/A year-over-year, with the annual reading at $126042.0 for FY2012, 8.97% up from the prior year.
- Research & Development for Q3 2023 was $7250.0 at Vycor Medical, down from $7550.0 in the prior quarter.
- The five-year high for Research & Development was $7550.0 in Q2 2023, with the low at $5508.0 in Q1 2023.